| 000 | 01745 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517195735.0 | ||
| 264 | 0 | _c20180810 | |
| 008 | 201808s 0 0 eng d | ||
| 022 | _a2092-9382 | ||
| 024 | 7 |
_a10.3341/kjo.2016.0134 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoon, Su Young | |
| 245 | 0 | 0 |
_aBevacizumab versus Dexamethasone Implant Followed by Bevacizumab for the Treatment of Macula Edema Associated with Branch Retinal Vein Occlusion. _h[electronic resource] |
| 260 |
_bKorean journal of ophthalmology : KJO _c02 2018 |
||
| 300 |
_a29-37 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aBevacizumab _xtherapeutic use |
| 650 | 0 | 4 |
_aDexamethasone _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Implants |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGlucocorticoids _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntravitreal Injections |
| 650 | 0 | 4 |
_aMacular Edema _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRetina _xpathology |
| 650 | 0 | 4 |
_aRetinal Vein Occlusion _xcomplications |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTomography, Optical Coherence |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aVisual Acuity _xphysiology |
| 700 | 1 | _aCho, Kwan Hyuk | |
| 700 | 1 | _aWoo, Se Joon | |
| 700 | 1 | _aPark, Sung Pyo | |
| 700 | 1 | _aKim, Yong Kyu | |
| 773 | 0 |
_tKorean journal of ophthalmology : KJO _gvol. 32 _gno. 1 _gp. 29-37 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3341/kjo.2016.0134 _zAvailable from publisher's website |
| 999 |
_c28020237 _d28020237 |
||